7 Guidelines_Short SW.ppt

7 Guidelines_Short SW.ppt - Cholesterol : Adult Treatment...

Info iconThis preview shows pages 1–9. Sign up to view the full content.

View Full Document Right Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: Cholesterol : Adult Treatment Panel III (ATP III) Guidelines http://www.nhlbi.nih.gov/guidelines/cholesterol/atglance.pdf Blood Pressure : Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) http://www.nhlbi.nih.gov/guidelines/hypertension/express.pdf Diabetes : American Diabetes Association http://care.diabetesjournals.org/content/32/Supplement_1/S13.full Obesity : The National Heart, Lung, and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf CVD Risk Factor Treatment Guidelines Adult Treatment Panel III (ATP III) Guidelines National Cholesterol Education Program Goals: 1) Primary prevention of CHD in those with high LDL-C 2) Intensive LDL-C lowering therapy in those with multiple risk factors Other Considerations: 1) Multiple metabolic risk factors (metabolic syndrome) Intensified therapeutic lifestyle changes 2) More Intensive Lifestyle Intervention (Therapeutic Lifestyle Changes = TLC) Weight management and physical activity 3 Cholesterol Classification 4 ATP III Categories of Risk 1) CHD and CHD risk equivalents Coronary Heart Disease Peripheral Artery Disease Abdominal Aortic Aneurysm Using Framingham - 10 yr risk >20% = CHD equivalent 2) Multiple (2+) risk factors Framingham 10 yr risk < 20% 3) 0-1 risk factor 5 6 Therapeutic Lifestyle Changes in LDL Lowering Therapy TLC Diet Reduced intake of cholesterol-raising nutrients Saturated fats <7% of total calories Dietary cholesterol <200 mg per day LDL-lowering therapeutic options Plant stanols/sterols (2 g per day) Viscous (soluble) fiber (1025 g per day) Weight reduction Increased physical activity 7 Benefit Beyond LDL Lowering: The Metabolic Syndrome as a Secondary Target of Therapy General Features of the Metabolic Syndrome Abdominal obesity Waist Circ. >40in men, >35in women Triglycerides > 150mg/dl HDL <40 mg/dl men, <50mg/dl women Raised blood pressure (> 130/> 85 mmHg) Fasting blood glucose (> 110mg/dl) Treat overweight/obesity Treat HTN, cholesterol Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) EXPRESS National Heart, Lung, and Blood Institute National High Blood Pressure Education Program...
View Full Document

Page1 / 27

7 Guidelines_Short SW.ppt - Cholesterol : Adult Treatment...

This preview shows document pages 1 - 9. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online